Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma Metastatic

Clinical trial condition

Melanoma Metastatic

Explore clinical trials studying Melanoma Metastatic. Study availability and eligibility vary by location and protocol.

16 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Melanoma Metastatic trial results

Not Yet Recruiting

A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma

NCT07651618

Conditions: Melanoma, Melanoma (Skin Cancer), Melanoma Metastatic, +11 more
Locations: Royal Perth Hospital Perth, Western Australia, Australia

View Trial Details

Not Yet Recruiting

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

NCT07442292

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations: Not specified

View Trial Details

Completed

Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study

NCT03879395

Conditions: Abdominal Neoplasms, Abdominal Tumor, Melanoma, +13 more
Locations: Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Active, Not Recruiting

Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

NCT07376317

Conditions: Cutaneous Melanoma, Melanoma, Melanoma Metastatic, +13 more
Locations: ICESP São Paulo, Brazil

View Trial Details

Active, Not Recruiting

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

NCT06784648

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +27 more
Locations: Charité - Universitatsmedizin Berlin Berlin, Germany

University Hospital Essen Essen, Germany

University Hospital Heidelberg Heidelberg, Germany

University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg and Clinical Cooperation Unit Dermato-Oncology(G300) German Cancer Research Center(DKFZ) Mannheim, Germany

View Trial Details

Active, Not Recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

NCT05732805

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +16 more
Locations: Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary" Babruysk, Belarus

Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus

Health care institution "Grodno University Clinic" Grodno, Belarus

Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus

View all 63 locations

View Trial Details